Technology from a South San Francisco startup could eliminate the need for finger pricks altogether. Profusa announced in January a series of implant devices that can be used to continuously measure glucose and other blood chemistry elements. The devices, which are about a tenth of an inch long, are injected under the skin and can provide measurements for up to two years with the aid of a special reader and a smartphone app […]

This article was originally published by USA Today: Read the full article here (page 5-7).